Alejandra Cavazos Saldana
Overview
Explore the profile of Alejandra Cavazos Saldana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
28
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zenner M, Kirkpatrick B, Leonardo T, Schlicht M, Saldana A, Loitz C, et al.
J Extracell Biol
. 2024 Mar;
2(11).
PMID: 38496750
Prostate cancer is the second leading cause of malignancy-related deaths among American men. Active surveillance is a safe option for many men with less aggressive disease, yet definitively determining low-risk...
2.
Zenner M, Kirkpatrick B, Leonardo T, Schlicht M, Saldana A, Loitz C, et al.
bioRxiv
. 2023 May;
PMID: 37214878
Prostate cancer is the second leading cause of malignancy-related deaths among American men. Active surveillance is a safe option for many men with less aggressive disease, yet definitively determining low-risk...
3.
Kaur S, Saldana A, Elkahloun A, Petersen J, Arakelyan A, Singh S, et al.
J Cell Commun Signal
. 2021 Nov;
16(3):397-419.
PMID: 34841476
CD47 is a marker of self and a signaling receptor for thrombospondin-1 that is also a component of extracellular vesicles (EVs) released by various cell types. Previous studies identified CD47-dependent...
4.
Ruiz-Rodado V, Lita A, Dowdy T, Celiku O, Saldana A, Wang H, et al.
Cancer Metab
. 2020 Oct;
8:23.
PMID: 33101674
Background: Targeting glutamine metabolism in cancer has become an increasingly vibrant area of research. Mutant IDH1 (IDH1 ) gliomas are considered good candidates for targeting this pathway because of the...